Goldman Sachs’s Exicure XCUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-985
Closed -$29K 6759
2022
Q1
$29K Buy
985
+756
+330% +$23.2K ﹤0.01% 6359
2021
Q4
$7K Buy
229
+3
+1% +$348 ﹤0.01% 6423
2021
Q3
$41K Sell
226
-276
-55% -$56K ﹤0.01% 6083
2021
Q2
$113K Buy
502
+93
+23% +$24.4K ﹤0.01% 5915
2021
Q1
$134K Buy
409
+109
+36% +$37.5K ﹤0.01% 5766
2020
Q4
$80K Buy
300
+179
+148% +$44.8K ﹤0.01% 5325
2020
Q3
$32K Sell
121
-633
-84% -$207K ﹤0.01% 5228
2020
Q2
$276K Sell
754
-1,175
-61% -$426K ﹤0.01% 4666
2020
Q1
$428K Buy
1,929
+1,525
+377% +$482K ﹤0.01% 4296
2019
Q4
$173K Buy
+404
New +$165K ﹤0.01% 4930

Other funds holding XCUR

Goldman Sachs's XCUR Position: Q2 2022 in Review

Goldman Sachs sold out of Exicure (XCUR) in Q2 2022, closing a stake of 985 shares — an estimated $29K sold.

Goldman Sachs first reported a position in XCUR in Q4 2019 and held it in 10 quarters. The position peaked at $428K in Q1 2020. 18 funds tracked by Wall St. Rank hold XCUR as of Q2 2022.

  • Goldman Sachs reported no remaining Exicure position as of Q2 2022 after selling out during the quarter.
  • Goldman Sachs sold 985 Exicure shares in Q2 2022, an estimated $29K.
  • Goldman Sachs first reported a position in Exicure in Q4 2019 and held it in 10 quarters.
  • Goldman Sachs's Exicure position peaked at $428K in Q1 2020.
  • 18 funds tracked by Wall St. Rank held Exicure as of Q2 2022.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.